The invention belongs to the technical field of
biosynthesis, and particularly relates to a method for regulating and controlling
stevioside production through a UDPG synthesis
route. According to the invention, a high-efficiency
stevioside biosynthesis system is constructed through systematic
engineering modification: in the aspect of
chassis cell optimization, transcription factors (AtWRKY18, AtWRKY40 and AtMYC2) for regulating and controlling MEP pathway and
key genes (dxs and / or dxr) of the MEP pathway are over-expressed, so that supply of
terpene precursors is enhanced; and a
heterologous MVA pathway (over-expression T7-atoB-mvaS-mvaE-mvK / mvKmut-pmK-mvaD-idi) with a
modular design is introduced, so that sufficient supply of the
terpenoid precursor is realized. Meanwhile, the
intracellular concentration of the UDPG is increased by systematically enhancing a UDPG synthesis pathway (knocking out ugd, glgc, ushA, agp, deoA, tdk, udp, or thrA, and overexpressing galU, pgm, pyrE, pyrH, ugpA, or prs), so that the production capacity of the
stevioside is remarkably improved.